Investor directoryLongGame
LongGame focuses exclusively on radical lifespan extension technologies that aim to slow or reverse aging.
The facts
- Typical cheque
- €100k – €10M
- Headquarters
- London, United Kingdom
- Founded
- 2024
Selected portfolio
Enhanced Games (NYS: ENHA)Oisin BiotechnologiesR3 Bio (Drug Delivery)Deciduous TherapeuticsVincere BiosciencesImmuneBridgeRevel PharmaceuticalsRenewalBioTelos BiotechRepair BiotechnologiesTotality BiosciencesRevel PharmaSyntax BioHerasightEnhanced GamesAperture TherapeuticsRenewal BioImmune BridgeGeneral ProximityDeciduousOisin BioVincere BioAdaptyv BioLucis Life
and 3 more
Questions founders ask
- How much does LongGame typically invest?
- LongGame states a typical cheque of €100k – €10M.
- Which stages does LongGame invest in?
- LongGame invests at Pre-Seed, Seed and Series A.
- Where is LongGame based?
- LongGame is headquartered in London, United Kingdom.
Does LongGame fit your round?
In 30 minutes you'll know which funds matter for your round.
Request accessAre you LongGame? Tell us what to correct and we will update it — or ask us to remove the entry.